Proliferative and Apoptotic Markers in Prostate Carcinoma in Relation to
Androgen Receptor
Dvořáčková J.1, Čeganová L.1, Štěrba J.1, Nedbálek A.2, Kolář Z.3
1CGB laboratoř spol. s r.o., Ostrava 2Urologické oddělení Nemocnice Vítkovice, Ostrava 3Ústav patologie a LMP LF UP a FN, Olomouc |
|
Summary:
Prostate carcinoma, one of the most frequent male malignancies, is in certain stages of its
development significantly influenced by androgens. Therefore, we carried out a retrospective
study on a set of 130 patients with nongeneralized, localized prostate carcinoma (stage T1-T2, PSA
up to 25 ng/ml). We determined immunohistochemically the expression of proliferation markers
PCNA and Ki67, Bax, p53, Bcl-2, p21waf1, p27kip1 and compared them with the expression of the
androgen receptor (AR). Multivariation statistical analysis of the results using the chi-square test
with Pearson’s correction and variability analysis using the SPSS 8.0 software program showed
a strong correlation of the PCNA and Ki67 proliferation markers with the expression of hormonal
dependence and apoptosis markers. The expression of PCNA correlated strongly with p27 kip1 and
Bax, while the expression of Ki67 correlated most strongly with p27 kip1 and Bcl-2. The expression
of p27 kip1 correlated with the expression of androgen receptor, PCNA, Ki67 as well as Bcl-2. None
of the observed markers correlated significantly with Gleason’s score. We did not find substantial
significant relation between the observed markers and the expression of p53 and p21 waf1. The
results indicate a significant role of the expression of p27 kip1 protein in regulating proliferative
activity and hormonal responsiveness in the initial stage of prostate carcinoma.
Key words:
prostate carcinoma – androgen receptor - Ki67 - PCNA - Bax – Bcl-2 - p53 - p21waf1 -
p27kip1 – carcinogenesis – hormone sensitivity
|